Here are the results of combo trial at 350mg dose.
Post# of 148187
(Total Views: 293)
Posted On: 09/20/2019 8:37:53 AM
Re: xxxSchlingelxxx #8417
Here are the results of combo trial at 350mg dose.
The primary endpoint for combo trial was <50 c/ml at one week. It achieved 64%, far superior to maraviroc.
The main secondary outcome was <50 c/ml at 25 weeks. It achieved 81% for all patients.
Even at the 350 mg dose we would have been approvable.
You sold some shares. Today I'm buying more shares.
The primary endpoint for combo trial was <50 c/ml at one week. It achieved 64%, far superior to maraviroc.
The main secondary outcome was <50 c/ml at 25 weeks. It achieved 81% for all patients.
Even at the 350 mg dose we would have been approvable.
You sold some shares. Today I'm buying more shares.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼